Gestational triphenyl phosphate exposure in C57Bl/6 mice perturbs expression of insulin‐like growth factor signaling genes in maternal and fetal liver2. Issue 6 (8th January 2018)

• Record Type: Journal Article
• Authors: Philbrook, Nicola A.; Restivo, Victoria E.; Belanger, Christine L.; Winn, Louise M.
• Is Part Of: Birth defects research. Volume 110:Issue 6(2018)
• Page Start: 483
• Page End: 494
• Publication Date: 2018-01-08
• Subjects: birth defects -- C57Bl/6 mice -- development -- insulin‐like growth factor -- triphenyl phosphate; Teratology -- Periodicals; Abnormalities, Human -- Periodicals; Congenital Abnormalities; Embryo, Mammalian -- abnormalities; Teratology; Abnormalities, Human; Teratology; Periodicals; Periodicals; 616.043
• DOI: 10.1002/bdr2.1185
• Languages: English
• ISSNs: 2472-1727

Abstract

Abstract : Triphenyl phosphate (TPhP) is an organophosphorus flame retardant and plasticizer that has been added to numerous consumer products in recent years. TPhP is not overtly toxic, however recent studies have suggested that it may have metabolic disrupting effects following developmental exposure. The present study aimed to investigate the developmental and potential metabolic effects of TPhP in a murine model. C57Bl/6 dams were exposed on gestational days (GD) 8, 10, 12, and 14 to 0, 5, 25, or 50 mg/kg TPhP via intraperitoneal injection. Dams were euthanized on GD19, maternal organs excised and weighed, fetal measurements taken, and maternal and fetal livers retained for analysis. A significant increase in placenta size of TPhP exposed mice was found. Maternal and fetal liver gene expression of insulin‐like growth factor ( Igf ) 1 and 2, as well as downstream genes involved in Igf signaling were measured. Additionally, Igf1 protein levels were measured in both maternal and fetal liver. A significant decrease in transcript levels of Igf1 and Irs2 was detected in maternal livers, whereas a significant increase in transcript levels of all genes measured was detected in fetal liver. A significant decrease in Igf1 protein levels was detected in maternal liver, however the increase in Igf1 protein levels in fetal livers was not found to be statistically significant. These results support previous findings that TPhP does not cause overt structural developmental toxicity. These data also support the hypothesis that TPhP could disrupt maternal and fetal metabolism, justifying the need for follow‐up studies to investigate further.